SANUWAVE Health, Inc. (SNWV) Analysts See $-0.01 EPS

March 15, 2018 - By Winifred Garcia

 SANUWAVE Health, Inc. (SNWV) Analysts See $ 0.01 EPS

Analysts expect SANUWAVE Health, Inc. (OTCMKTS:SNWV) to report $-0.01 EPS on April, 3.They anticipate $0.01 EPS change or 50.00 % from last quarter’s $-0.02 EPS. After having $-0.01 EPS previously, SANUWAVE Health, Inc.’s analysts see 0.00 % EPS growth. The stock decreased 4.20% or $0.01 during the last trading session, reaching $0.51. About 285,064 shares traded. SANUWAVE Health, Inc. (OTCMKTS:SNWV) has 0.00% since March 15, 2017 and is . It has underperformed by 16.70% the S&P500.

SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic pressure shockwaves for regenerative medicine and other applications. The company has market cap of $71.02 million. The Company’s shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It currently has negative earnings. The company's lead product candidate is the dermaPACE device, which has completed its initial Phase III, IDE clinical trial for treating diabetic foot ulcers.

More notable recent SANUWAVE Health, Inc. (OTCMKTS:SNWV) news were published by: which released: “SANUWAVE HEALTH TO PRESENT AT THE 2018 BIO CEO & INVESTOR CONFERENCE” on January 30, 2018, also with their article: “Uptick Newswire “Stock Day” Interviews CEO of SANUWAVE Health on the 2018 …” published on January 10, 2018, published: “Sanuwave Health to Participate at 2018 Anti-Biofilm Technologies Conference in …” on January 26, 2018. More interesting news about SANUWAVE Health, Inc. (OTCMKTS:SNWV) were released by: and their article: “SANUWAVE Health, Inc., CEO Kevin Richardson Returns to Uptick Newswire’s …” published on February 21, 2018 as well as‘s news article titled: “SANUWAVE Health to Hold Call to Discuss FDA Approval Letter on Tuesday …” with publication date: December 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: